Procyon Advisors LLC Acquires 4,254 Shares of Intuitive Surgical, Inc. $ISRG

Procyon Advisors LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 787.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,794 shares of the medical equipment provider’s stock after purchasing an additional 4,254 shares during the period. Procyon Advisors LLC’s holdings in Intuitive Surgical were worth $2,715,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Cyndeo Wealth Partners LLC lifted its stake in Intuitive Surgical by 20.9% in the fourth quarter. Cyndeo Wealth Partners LLC now owns 8,458 shares of the medical equipment provider’s stock valued at $4,790,000 after buying an additional 1,462 shares in the last quarter. Magnus Financial Group LLC boosted its holdings in shares of Intuitive Surgical by 11.3% in the fourth quarter. Magnus Financial Group LLC now owns 837 shares of the medical equipment provider’s stock valued at $474,000 after buying an additional 85 shares during the period. Impact Capital Partners LLC boosted its holdings in shares of Intuitive Surgical by 17.9% in the fourth quarter. Impact Capital Partners LLC now owns 744 shares of the medical equipment provider’s stock valued at $421,000 after buying an additional 113 shares during the period. Everpar Advisors LLC raised its holdings in shares of Intuitive Surgical by 13.0% during the fourth quarter. Everpar Advisors LLC now owns 1,148 shares of the medical equipment provider’s stock worth $650,000 after acquiring an additional 132 shares during the period. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in shares of Intuitive Surgical by 10.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,400 shares of the medical equipment provider’s stock worth $793,000 after acquiring an additional 136 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.5%

Intuitive Surgical stock opened at $477.76 on Monday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88. The company has a fifty day simple moving average of $502.83 and a 200 day simple moving average of $513.46. The company has a market cap of $169.67 billion, a P/E ratio of 60.55, a price-to-earnings-growth ratio of 3.69 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the previous year, the firm posted $2.21 EPS. The company’s revenue for the quarter was up 18.8% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Fundamentals remain strong — Intuitive reported an earnings beat and double‑digit revenue growth in its latest quarter, supporting the company’s long‑term growth thesis and valuation premium. Bull of the Day: Intuitive Surgical (ISRG)
• Positive Sentiment: Prominent bullish mentions — coverage including a “Bull of the Day” piece and a Jim Cramer mention keep ISRG on the buy/hold radar for growth investors, which can support buying interest after negative headlines. Jim Cramer Analyzed 5 Stocks
• Neutral Sentiment: Comparative analyses and sector commentary (head‑to‑head pieces) provide context but no immediate catalyst; these may influence longer‑term positioning rather than intraday moves. Head‑To‑Head Analysis: Lombard Medical & Intuitive Surgical
• Negative Sentiment: FDA safety flag on stapler devices — regulators have flagged safety concerns and advised halting affected devices, which is a near‑term operational and reputational risk that likely pressured the stock. FDA Flags Safety Concern Over Intuitive Surgical Stapler
• Negative Sentiment: Company warning and reported death related to stapler reloads — Intuitive issued warnings after at least one reported death, increasing legal, recall and adoption‑risk concerns for affected products. Intuitive warns on surgical stapler reloads with one death reported
• Negative Sentiment: Broader quality and cybersecurity scrutiny — reporting highlights recalls and other operational snags (including cyber incidents), which amplify investor uncertainty about near‑term execution and regulatory exposure. From Cyber Criminals to Recalls: Inside Intuitive Surgical’s Newest Snag
• Negative Sentiment: Technical weakness — the stock recently formed a “death cross” (50‑day moving average crossing below the 200‑day), which can trigger momentum selling from technical traders even if fundamentals remain solid. Intuitive Surgical Stock Just Flashed A Death Cross

Insider Buying and Selling

In related news, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 32,943 shares of company stock worth $17,279,568. Insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Barclays set a $712.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. Wells Fargo & Company boosted their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a research report on Wednesday, March 11th. Finally, Truist Financial increased their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $614.95.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.